ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1LLY • US5324571083

887.7 EUR
+9.4 (+1.07%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

6

1LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY shows excellent growth, but is valued quite expensive already. These ratings could make 1LLY a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year 1LLY was profitable.
  • In the past year 1LLY had a positive cash flow from operations.
  • Each year in the past 5 years 1LLY has been profitable.
  • In the past 5 years 1LLY always reported a positive cash flow from operatings.
1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCF1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • 1LLY's Return On Assets of 16.02% is amongst the best of the industry. 1LLY outperforms 89.09% of its industry peers.
  • 1LLY's Return On Equity of 77.38% is amongst the best of the industry. 1LLY outperforms 96.36% of its industry peers.
  • 1LLY has a better Return On Invested Capital (28.84%) than 94.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1LLY is significantly above the industry average of 14.23%.
  • The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.84%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1LLY.MI Yearly ROA, ROE, ROIC1LLY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • 1LLY's Profit Margin of 30.99% is amongst the best of the industry. 1LLY outperforms 96.36% of its industry peers.
  • 1LLY's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 44.41%, 1LLY belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
  • 1LLY's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 83.03%, 1LLY belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
  • 1LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
1LLY.MI Yearly Profit, Operating, Gross Margins1LLY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • 1LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1LLY remains at a similar level compared to 1 year ago.
  • 1LLY has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1LLY has a worse debt to assets ratio.
1LLY.MI Yearly Shares Outstanding1LLY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1LLY.MI Yearly Total Debt VS Total Assets1LLY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 8.22 indicates that 1LLY is not in any danger for bankruptcy at the moment.
  • 1LLY has a better Altman-Z score (8.22) than 90.91% of its industry peers.
  • 1LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as 1LLY would need 6.60 years to pay back of all of its debts.
  • 1LLY has a Debt to FCF ratio of 6.60. This is in the lower half of the industry: 1LLY underperforms 60.00% of its industry peers.
  • 1LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.72, 1LLY is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.22
ROIC/WACC3.1
WACC9.3%
1LLY.MI Yearly LT Debt VS Equity VS FCF1LLY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that 1LLY should not have too much problems paying its short term obligations.
  • 1LLY has a Current ratio (1.55) which is comparable to the rest of the industry.
  • 1LLY has a Quick Ratio of 1.24. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1LLY's Quick ratio of 1.24 is fine compared to the rest of the industry. 1LLY outperforms 67.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
1LLY.MI Yearly Current Assets VS Current Liabilites1LLY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 116.22% over the past year.
  • 1LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
  • Looking at the last year, 1LLY shows a very strong growth in Revenue. The Revenue has grown by 45.41%.
  • 1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%

3.2 Future

  • The Earnings Per Share is expected to grow by 32.61% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 19.64% on average over the next years. This is quite good.
EPS Next Y84.93%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
EPS Next 5Y32.61%
Revenue Next Year41.38%
Revenue Next 2Y31.01%
Revenue Next 3Y26.06%
Revenue Next 5Y19.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1LLY.MI Yearly Revenue VS Estimates1LLY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
1LLY.MI Yearly EPS VS Estimates1LLY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 47.62, 1LLY can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, 1LLY is valued a bit more expensive than 69.09% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1LLY to the average of the S&P500 Index (27.92), we can say 1LLY is valued expensively.
  • 1LLY is valuated quite expensively with a Price/Forward Earnings ratio of 31.61.
  • Based on the Price/Forward Earnings ratio, 1LLY is valued a bit more expensive than 70.91% of the companies in the same industry.
  • 1LLY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 47.62
Fwd PE 31.61
1LLY.MI Price Earnings VS Forward Price Earnings1LLY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than 67.27% of the companies in the same industry.
  • 67.27% of the companies in the same industry are cheaper than 1LLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 153.83
EV/EBITDA 35.78
1LLY.MI Per share data1LLY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of 1LLY may justify a higher PE ratio.
  • 1LLY's earnings are expected to grow with 46.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)2.87
EPS Next 2Y59.63%
EPS Next 3Y46.9%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.68%, 1LLY is not a good candidate for dividend investing.
  • 1LLY's Dividend Yield is comparable with the industry average which is at 1.95.
  • Compared to an average S&P500 Dividend Yield of 1.83, 1LLY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of 1LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 28.28% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
  • 1LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
1LLY.MI Yearly Income VS Free CF VS Dividend1LLY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B
1LLY.MI Dividend Payout.1LLY.MI Dividend Payout, showing the Payout Ratio.1LLY.MI Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

BIT:1LLY (2/6/2026, 7:00:00 PM)

887.7

+9.4 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap839.21B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts81.08
Price Target960.46 (8.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.14
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)3.76%
PT rev (3m)20.91%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)1.17%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)6.01%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE 47.62
Fwd PE 31.61
P/S 16.66
P/FCF 153.83
P/OCF 61.64
P/B 41.61
P/tB 86.48
EV/EBITDA 35.78
EPS(TTM)18.64
EY2.1%
EPS(NY)28.08
Fwd EY3.16%
FCF(TTM)5.77
FCFY0.65%
OCF(TTM)14.4
OCFY1.62%
SpS53.27
BVpS21.33
TBVpS10.26
PEG (NY)0.56
PEG (5Y)2.87
Graham Number94.59
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.84%
ROICexc 33.25%
ROICexgc 41.06%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.22
F-Score7
WACC9.3%
ROIC/WACC3.1
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.93%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
EPS Next 5Y32.61%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.38%
Revenue Next 2Y31.01%
Revenue Next 3Y26.06%
Revenue Next 5Y19.64%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.81%
EBIT Next 3Y47.2%
EBIT Next 5Y33.2%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%

ELI LILLY & CO / 1LLY.MI FAQ

What is the fundamental rating for 1LLY stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.


What is the valuation status of ELI LILLY & CO (1LLY.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.


Can you provide the profitability details for ELI LILLY & CO?

ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.


What is the expected EPS growth for ELI LILLY & CO (1LLY.MI) stock?

The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 84.93% in the next year.


Is the dividend of ELI LILLY & CO sustainable?

The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.